# Impact of a molecular syndromic panel on Clostridioides difficile detection and clinical interpretation

## TL;DR

A new molecular test for infectious diarrhea changed how often Clostridioides difficile is classified as a harmless presence rather than an infection.

## Contribution

The study shows that molecular syndromic panels may lead to reclassification of C. difficile results, suggesting a need for revised reporting practices.

## Key findings

- After implementing a molecular syndromic panel, more C. difficile results were classified as colonization.
- This shift suggests diagnostic uncertainty in some patients, prompting a re-evaluation of routine reporting.

## Abstract

After implementation of a molecular syndromic panel for infectious diarrhea, a significantly greater proportion of C. difficile results were classified as colonization rather than infection compared to the pre-implementation period. Routine C. difficile reporting from multiplex panels should be re-evaluated to minimize diagnostic uncertainty in some patients.